+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Genotyping and immunohistochemistry of gastrointestinal stromal tumors: An update



Genotyping and immunohistochemistry of gastrointestinal stromal tumors: An update



Seminars in Diagnostic Pathology 32(5): 392-399



Gastrointestinal stromal tumors (GISTs) were originally thought to harbor either KIT or platelet-derived growth factor receptor A (PDGFRA) mutations only. However, more recent discoveries have highlighted additional, less common oncogenic driver mutations including NF1, BRAF, and succinate dehydrogenase (SDH) mutations. Genotyping GISTs has become more important since not all genotypes respond equally to FDA-approved tyrosine kinase inhibitors. GIST is a paradigm for personalized cancer therapy. Recent studies demonstrate how immunohistochemistry can be used both to diagnose GIST and to screen for specific mutations. DOG1 is particularly useful in the diagnosis of KIT-negative GIST, including tumors with PDGFRA mutations, which can also potentially be identified by immunohistochemistry for PDGFRA. SDHB immunohistochemistry is useful in characterizing GISTs with SDHA-D mutations, whereas SDHA immunohistochemistry is able to identify SDHA mutant GISTs.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057938277

Download citation: RISBibTeXText

PMID: 25766843

DOI: 10.1053/j.semdp.2015.02.017


Related references

The Immunohistochemistry of Gastrointestinal Stromal Tumors. The American Journal of Surgical Pathology 11(6): 464-473, 1987

Immunohistochemistry of gastrointestinal stromal tumors. Laboratory Investigation 54(1): 51A, 1986

The diagnostic value of immunohistochemistry in gastrointestinal stromal tumors. Virchows Archiv 435(3): 170, 1999

Study on gastrointestinal stromal tumors by electron microscopy and immunohistochemistry. Zhonghua Bing Li Xue Za Zhi 32(2): 101-105, 2003

Histomorphology and Immunohistochemistry of Gastrointestinal Stromal Tumors in a Malaysian Population. Asian Pacific Journal of Cancer Prevention 17(6): 2795-2799, 2016

Immunohistochemistry and c-kit gene analysis in determining malignancy in gastrointestinal stromal tumors. Hepato-Gastroenterology 50(53): 1431-1435, 2003

Gastrointestinal stromal tumors Diagnosis by fine needle aspiration and immunohistochemistry. Acta Cytologica 44(5): 909, September-October, 2000

Does immunohistochemistry provide additional prognostic data in gastrointestinal stromal tumors?. Asian Pacific Journal of Cancer Prevention 14(8): 4751-4758, 2013

Use of tissue microarrays and immunohistochemistry to standardize the diagnosis of gastrointestinal stromal tumors. Pathology International 60(11): 707-713, 2010

Subclassification of gastrointestinal stromal tumors based on evaluation by electron microscopy and immunohistochemistry. Ultrastructural Pathology 20(4): 373-393, 1996

The immunohistochemistry of gastrointestinal stromal tumors. Evidence supporting an origin from smooth muscle. American Journal of Surgical Pathology 11(6): 464-473, 1987

Comparison of tissue microarray and full section in immunohistochemistry of gastrointestinal stromal tumors. Pathology International 59(12): 851-856, 2009

Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types. American Journal of Surgical Pathology 34(5): 636-644, 2010

The prognostic significance of ING4 expression on gastric gastrointestinal stromal tumors by immunohistochemistry. Annali Italiani di Chirurgia 88: 311-317, 2017

Gastrointestinal stromal tumors: usefulness of immunohistochemistry, flow cytometry and fluorescence in situ hybridization. Journal of Gastroenterology and Hepatology 22(11): 1754-1759, 2007